Literature DB >> 8690144

Hexosamines and insulin resistance.

D A McClain1, E D Crook.   

Abstract

Glucose is an important regulator of cell growth and metabolism. Thus, it is likely that some of the adverse effects of hyperglycemia are reflections of normal regulation by abnormal concentrations of glucose. How the cell senses glucose, however, is still incompletely understood. Evidence has been presented that the hexosamine biosynthesis pathway serves this function for regulation of aspects of glucose uptake, glycogen synthesis, glycolysis, and synthesis of growth factors. Excess hexosamine flux causes insulin resistance in cultured cells, tissues, and intact animals. Further evidence for the possible role of this pathway in normal glucose homeostasis and disease is that the level of activity of the rate-limiting enzyme in hexosamine synthesis, glutamine:fructose-6-phosphate amidotransferase, is correlated with glucose disposal rates (GDRs) in normal humans and transgenic mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690144     DOI: 10.2337/diab.45.8.1003

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  62 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

Review 2.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 3.  Plasma leptin and exercise: recent findings.

Authors:  Matthew W Hulver; Joseph A Houmard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 4.  Fluidity of insulin action.

Authors:  Jeffrey S Elmendorf
Journal:  Mol Biotechnol       Date:  2004-06       Impact factor: 2.695

5.  Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition.

Authors:  Sang Yoon Park; Hyun Sil Kim; Nam Hee Kim; Suena Ji; So Young Cha; Jeong Gu Kang; Ichiro Ota; Keiji Shimada; Noboru Konishi; Hyung Wook Nam; Soon Won Hong; Won Ho Yang; Jürgen Roth; Jong In Yook; Jin Won Cho
Journal:  EMBO J       Date:  2010-10-19       Impact factor: 11.598

6.  Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction.

Authors:  Rob H P Hilgers; Dongqi Xing; Kaizheng Gong; Yiu-Fai Chen; John C Chatham; Suzanne Oparil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-09       Impact factor: 4.733

Review 7.  The metabolic syndrome and the heart--a considered opinion.

Authors:  J G Leichman; V R Lavis; D Aguilar; C R Wilson; H Taegtmeyer
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

Review 8.  "Actin"g on GLUT4: membrane & cytoskeletal components of insulin action.

Authors:  Joseph T Brozinick; Bradley A Berkemeier; Jeffrey S Elmendorf
Journal:  Curr Diabetes Rev       Date:  2007-05

9.  A genetic model to study O-GlcNAc cycling in immortalized mouse embryonic fibroblasts.

Authors:  Melissa M St Amand; Michelle R Bond; Julia Riedy; Marcella Comly; Joseph Shiloach; John A Hanover
Journal:  J Biol Chem       Date:  2018-06-28       Impact factor: 5.157

Review 10.  Insulin resistance protects the heart from fuel overload in dysregulated metabolic states.

Authors:  Heinrich Taegtmeyer; Christophe Beauloye; Romain Harmancey; Louis Hue
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-04       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.